After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Q4 2024 Management View CEO Steve Spray highlighted strong fourth-quarter performance with improvements in combined ratios, premium growth, and a 38% increase in operating income to $497 million. Full ...

PennantPark Investment Corporation (PNNT) reported its earnings for the fourth quarter of 2024, revealing a slight miss on both earnings per share (EPS) and revenue forecasts. The company reported an ...